The industry’s leading scalable electroporation technology for high-yield, transient expression of proteins and rapid stable cell line development.
- Rapidly transfect from 75 thousand to 20 billion cells
- High efficiency enables flexible media strategies that can deliver significant cost savings
- Improved yields for decreased development timelines
- Proprietary Flow Electroporation™ Technology
- Faster production of stable clones
- ISO-certified and CE-marked